UBS’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q3 | $2K | Sell |
80
-90
| -53% | -$2.25K | ﹤0.01% | 6383 |
|
|
2014
Q2 | $6K | Sell |
170
-322
| -65% | -$11.4K | ﹤0.01% | 5950 |
|
|
2014
Q1 | $22K | Sell |
492
-49
| -9% | -$2.19K | ﹤0.01% | 5178 |
|
|
2013
Q4 | $21K | Sell |
541
-23,533
| -98% | -$913K | ﹤0.01% | 5173 |
|
|
2013
Q3 | $1.09M | Buy |
24,074
+4,864
| +25% | +$220K | ﹤0.01% | 2385 |
|
|
2013
Q2 | $943K | Buy |
+19,210
| New | +$943K | ﹤0.01% | 2446 |
|